Diagnosis of 22q11 deletion and duplication in congenital heart disease by multiplex ligation-dependent probe amplification

YANG Yue-Hua; HU Ya-Li; ZHU Xiang-Yu; MO Xu-Ming; WANG Dong-Jin; YAO Jin-Cui; SHENG Min; ZHU Hai-Yan; LI Jie; RU Tong; WANG Zhi-Qun

PDF(1069 KB)

Chinese Journal of Contemporary Pediatrics ›› 2009, Vol. 11 ›› Issue (12) : 892-896.

Diagnosis of 22q11 deletion and duplication in congenital heart disease by multiplex ligation-dependent probe amplification

YANG Yue-Hua, HU Ya-Li, ZHU Xiang-Yu, MO Xu-Ming, WANG Dong-Jin, YAO Jin-Cui, SHENG Min, ZHU Hai-Yan, LI Jie, RU Tong, WANG Zhi-Qun

Author information +

History +

Abstract

OBJECTIVE: To investigate the clinical utility of multiplex ligation-dependent probe amplification (MLPA) for detecting 22q11 deletion and duplication in congenital heart disease (CHD) cases and to study the incidence of 22q11 deletion and duplicaton in different kinds of CHD. METHODS: Forty-eight probes of which 25 located in 22q11 low copy number region (LCR 22s A-H), 7 in 22q11 surrounding region (CES, 22q13) and 16 in chromosomes 4, 8, 10 and 17 were selected to detect 22q11 deletion and duplication in 181 preoperative children with CHD and 14 fetuses with serious CHD or CHD with multiple malformations. In these cases, karyotype analysis was also performed. RESULTS: MLPA demonstrated that 7 cases had 22q11 deletion ［6 cases from CLTCL1 to LZTR1(LCR A-D) and 1 case from CLTCL1 to PCQAP (LCR A-C)］ and that 1 case had 22q11 duplication，spanning from ZNF74 to LZTR1(LCR B-D). The phenotypes of heart defect included ventricular septal defect, atrioventricular septal defect, pulmonary stenosis and tetralogy of Fallot. Karyotype analysis showed that 1 case had 21q deletion ［46, XY, 21q］, 1 case had mosaic trisomy 8 ［ 47,XY,+8/46, XY(1∶2)］ and 4 cases had trisomy 21. One of the 4 cases with trisomy 21 had concurrent 22q11 duplication. CONCLUSIONS: MLPA is a rapid, sensitive, site-specific and relatively inexpensive method for diagnosis of 22q11 deletion and duplication in CHD. 22q11 deletion and duplication may cause various kinds of CHD, suggesting that genetic detection should be performed routinely in CHD patients.［Chin J Contemp Pediatr, 2009, 11 (11):892-896］

Key words

22q11 deletion / 22q11 duplication / Congenital heart disease / Multiplex ligation-dependent probe amplification / Child / Fetus

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

YANG Yue-Hua, HU Ya-Li, ZHU Xiang-Yu, MO Xu-Ming, WANG Dong-Jin, YAO Jin-Cui, SHENG Min, ZHU Hai-Yan, LI Jie, RU Tong, WANG Zhi-Qun. Diagnosis of 22q11 deletion and duplication in congenital heart disease by multiplex ligation-dependent probe amplification[J]. Chinese Journal of Contemporary Pediatrics. 2009, 11(12): 892-896

References

［1］Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population［J］. Pediatrics, 2003, 112（1 Pt 1）：101-107.
［2］Kyburz A, Bauersfeld U, Schinzel A, Riegel M, Hug M, Tomaske M, et al.The fate of children with microdeletion 22q11.2 syndrome and congenital heart defect：clinical course and cardiac outcome［J］. Pediatr Cardiol, 2008, 29(1)：76-83.
［3］Park IS, Ko JK, Kim YH, Yoo HW, Seo EJ, Choi JY, et al. Cardiovascular anomalies in patients with chromosome 22q11.2 deletion：a Korean multicenter study［J］. Int J Cardiol, 2007, 114 (2)：230-235.
［4］许争峰，易龙，莫绪明，胡娅莉，王东进，朱瑞芳，等. 先天性心脏病患者22q11 微缺失检测及相关分析［J］. 中华医学遗传学杂志，2006，23(3)：250-255.
［5］许争峰，胡娅莉，张建伟，朱瑞芳，茹彤，刘启兰，等. 9 例18 三体综合征胎儿的产前诊断［J］. 中华围产医学杂志，2006，9 (5)：291-293.
［6］郑明明，胡娅莉，许争峰，王志群，史婷琦，叶晓东，等.实时荧光定量聚合酶链反应技术在产前诊断唐氏综合征中的应用［J］. 中华妇产科杂志，2004，39(10)：678-681.
［7］Jalali GR, Vorstman JA, Errami A, Vijzelaar R, Biegel J, Shaikh T, et al. Detailed analysis of 22q11.2 with a high density MLPA probe set［J］. Hum Mutat, 2008, 29(3)：433-440.
［8］Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification［J］. Nucleic Acids Res, 2002, 30(12)：e57.
［9］Fernández L, Lapunzina P, Arjona D, López Pajares I, García-Guereta L, Elorza D, et al. Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q 11.2 deletion syndrome［J］. Clin Genet, 2005, 68(4)：373-378.
［10］Stachon AC, Baskin B, Smith AC, Shugar A, Cytrynbaum C, Fishman L, et al. Molecular diagnosis of 22q11.2 deletion and duplication by multiplex ligation dependent probe amplification［J］. Am J Med Genet A, 2007,143A(24)：2924-2930.
［11］Shaikh TH, O′Connor RJ, Pierpont ME, McGrath J, Hacker AM, Nimmakayalu M, et al. Low copy repeats mediate distal chromosome 22q11.2 deletions： sequence analysis predicts breakpoint mechanisms［J］.Genome Res, 2007, 17(4)：482-491.
［12］Courtens W, Schramme I, Laridon A. Microduplication 22q11.2：a benign polymorphism or a syndrome with a very large clinical variability and reduced penetrance?—Report of two families［J］. Am J Med Genet A, 2008, 146A(6)：758-763.